• Citer

Combining 18F-FDG PET/CT-based metabolically active tumor volume and circulating cell-free DNA significantly improves outcome prediction in chemorefractory metastatic colorectal cancer

par Woff, Erwin ;Kehagias, Pashalina ;Vandeputte, Caroline;Ameye, Lieveke;Guiot, Thomas ;Paesmans, Marianne ;Hendlisz, Alain ;Flamen, Patrick
Référence The Journal of nuclear medicine, 60, 10, page (1366-1372)
Publication Publié, 2019-10-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Combining 18F-FDG PET/CT-based metabolically active tumor volume and circulating cell-free DNA significantly improves outcome prediction in chemorefractory metastatic colorectal cancer
Auteur:	Woff, Erwin; Kehagias, Pashalina; Vandeputte, Caroline; Ameye, Lieveke; Guiot, Thomas; Paesmans, Marianne; Hendlisz, Alain; Flamen, Patrick
Informations sur la publication:	The Journal of nuclear medicine, 60, 10, page (1366-1372)
Statut de publication:	Publié, 2019-10-01
Sujet CREF:	Imagerie médicale, radiologie, tomographie
Mots-clés:	18F-FDG PET/CT
	Circulating cell-free DNA
	Metabolically active tumor volume
	Metastatic colorectal cancer
	Multikinase inhibitors
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0161-5505
	info:doi/10.2967/jnumed.118.222919
	info:scp/85072848020
	info:pmid/30850494